Combivent Treatment Report

Category: Prescription Drugs

true

Generic Name: Ipratropium-Albuterol

What is Combivent?

An example of Combivent

Combivent® is a brand name for the drugs ipratropium bromide and albuterol sulfate (salbutamol), bronchodilators used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
Perceived Effectiveness
Purpose # of patients # of patients with evaluations
Major
Moderate
Slight
None
Can’t tell
15 0
9 0
9 1 Efficacy_cant_tell
3 2 Efficacy_moderate Efficacy_cant_tell
3 0
2 0

See all 48 patients currently taking Combivent

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
0
Moderate
0
Mild
0
None
6

Reported Dosages

Frequently reported dosages based on patients currently taking Combivent. See all 17 dosages

  90mcg-18mcg/inh as needed 2 90mcg-18mcg/inh as needed 1.5 mcg daily 2 mcg daily 4 other daily 90 mcg-18 mcg/inh daily 2 x 90 mcg-18 mcg/inh daily 3 x 90 mcg-18 mcg/inh daily 4 x 90 mcg-18 mcg/inh daily 8 x 90 mcg-18 mcg/inh daily
  12 Number of Patients: 12 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6 7 Number of Patients: 7 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Combivent (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 33%
Did not seem to work 1   Did not seem to work: 17%
Course of treatment ended 1   Course of treatment ended: 17%
Change in health plan coverage 1   Change in health plan coverage: 17%
Not indicated 1   Not indicated: 17%

See all 6 patients who’ve stopped taking Combivent

Currently Taking Combivent

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Combivent

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Combivent

Always
3 50%
Usually
0 0%
Sometimes
1 17%
Never
2 33%

Burden

Difficulty being on treatment

Burden of Combivent

Very
0 0%
Somewhat
1 17%
A little
1 17%
Not at all
4 67%

Cost

Paid out of pocket

Cost of Combivent

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
1 33%
< $25
2 67%

Sort by: Helpfulness | Most Recent

1 patient evaluation for Combivent

Purpose: General health (Started Jan 01, 2002)
Date Dosage Perceived effectiveness Side Effects Adherence Burden
Feb 15, 2009 As needed Led_efficacy_3Led_efficacy_3Led_efficacy_3Led_defaultModerate NoneNoneNoneNoneNone AlwaysAlwaysAlwaysAlwaysAlways Not at allNot at allNot at allNot at allNot at all
  • Icon_thumb_off 0 helpful marks

5 additional evaluations for Combivent are not currently shared publicly.

What is albuterol-ipratropium?

Albuterol and ipratropium are bronchodilators that relax muscles in the airways and increase air flow to the lungs.

The combination of albuterol and ipratropium inhalation is used to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD) who are also using other medicines to control their condition.

Albuterol and ipratropium inhalation may also be used for other purposes not listed in this medication guide.


Precautions

Do not use the albuterol and ipratropium inhaler (Combivent) if you are allergic to soybeans, peanuts, or other food products that contain soya lecithin.

Before using this medication, tell your doctor if you have:

  • heart disease, high blood pressure, or congestive heart failure;
  • a seizure disorder such as epilepsy;
  • diabetes;
  • overactive thyroid;
  • glaucoma;
  • an enlarged prostate or problems with urination; or
  • liver or kidney disease.

If you have any of these conditions, you may need a dose adjustment or special tests to safely take this medication.

FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment.

It is not known whether albuterol and ipratropium passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Avoid getting this medication in your eyes. If this does happen, rinse the eyes with water and seek medical attention.

Back to top

Instructions

Seek emergency medical attention if you think you have used too much of this medicine. An overdose of albuterol and ipratropium can be fatal. Overdose symptoms may include chest pain or heavy feeling, rapid or uneven heart rate, pain spreading to the arm or shoulder, nausea, sweating, weakness, or general ill feeling.

Use the medication as soon as you remember. If it is almost time for the next dose, skip the missed dose and use the medicine at the next regularly scheduled time. Do not use extra medicine to make up the missed dose.

Back to top

Side Effects

Stop using this medication and get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

Stop using albuterol and ipratropium and call your doctor at once if you have any of these serious side effects:

  • bronchospasm (wheezing, chest tightness, trouble breathing), especially after starting a new canister of this medicine;
  • chest pain and fast, pounding, or uneven heart beats;
  • swelling of your ankles or feet;
  • pain or burning with urination; or
  • increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure).

Less serious side effects may include:

  • headache, dizziness, nervousness;
  • drowsiness or sleep problems (insomnia);
  • cough, hoarseness, sore throat, runny or stuffy nose;
  • dry mouth, unusual taste in your mouth;
  • tremors, numbness or tingly feeling;
  • nausea, vomiting, upset stomach, diarrhea, constipation; or
  • blurred vision.

This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.

Back to top

Interactions

Before using this medication, tell your doctor if you are taking any of the following medicines:

  • atropine (Donnatal, and others);
  • belladonna;
  • clidinium (Quarzan);
  • dicyclomine (Bentyl);
  • glycopyrrolate (Robinul);
  • hyoscyamine (Anaspaz, Cystospaz, Levsin, and others);
  • mepenzolate (Cantil);
  • methantheline (Provocholine);
  • methscopolamine (Pamine), scopolamine (Transderm-Scop);
  • propantheline (Pro-Banthine);
  • a beta-blocker such as acebutolol (Sectral), atenolol (Tenormin), carvedilol (Coreg), metoprolol (Lopressor), or propranolol (Inderal);
  • a stimulant, ADHD medication, diet pills, or over-the-counter cold or allergy medicines;
  • a diuretic (water pill) such as furosemide (Lasix), bumetanide (Bumex), ethacrynic acid (Edecrin), torsemide (Demadex), hydrochlorothiazide (Hydrodiuril), chlorthalidone (Hygroton, Thalitone), or chlorothiazide (Diuril); or
  • an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate).

This list is not complete and there may be other drugs that can interact with albuterol and ipratropium. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.

Other Names

Combivent, DuoNeb, albuterol-ipratropium, and ipratropium-albuterol

Available Strengths & Dosages


Route Form Strength
inhalation aerosol with adapter 90 mcg-18 mcg/inh

Back to top

Disclaimer

Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 1996-2004 Cerner Multum, Inc. Version 2.05. Revision date 8/23/04

Last updated: